Pharm Exec 50: Growth from the Bottom UpByPatrick Clinton,Jerry CacciottiMay 1st 2012More consolidation didn't boost sales at the top, but a handful of nimble newcomers posted impressive growth on the other end of the curve.
Pharma's Next Top Model: Slimmer Business ModelsByBill Shew,Jerry CacciottiMarch 1st 2006The disease profiles pharma companies pursue should shape the business models that enable them to grow.